hair and miniaturization after 6 months of treatment
    Female 6/28/2024

    At a glance
    In this treatment experience post, the primary subjects mentioned are
    ๐Ÿ’Š Minoxidil (oral) 6 months
    ๐Ÿ’Š Spironolactone (oral) 6 months
    ๐Ÿ’ง Minoxidil (topical) 6 months
    the tone is ๐Ÿ˜ neutral with minimal regrowth results.

    Other terms

    A female user is experiencing minimal regrowth and miniaturized hair after 6 months of treatment with oral minoxidil, spironolactone, and topical minoxidil. She seeks advice on whether she can restore her remaining follicles.
    View this post in the Community โ†’

    Similar Community Posts Join

    5 / 1000+ results

    Related Research

    6 / 1000+ results
      Diffuse Hair Loss: Its Triggers and Management

      research Diffuse hair loss: Its triggers and management

      88 citations , June 2009 in “Cleveland Clinic Journal of Medicine”
      To manage diffuse hair loss, identify the cause, improve nutrition, remove triggers, and use specific treatments like minoxidil or finasteride.
      Telogen Effluvium: A Common Hair Loss Condition

      research Telogen effluvium

      April 2012 in “Informa Healthcare eBooks”
      Telogen effluvium is a common hair loss condition where many hairs enter the resting phase, often not noticeable until significant loss occurs, and treatment focuses on the underlying cause.
      Overactive Bladder in Men: Finasteride for Androgenetic Alopecia

      research Overactive bladder in men

      1 citations , January 2009 in “CRC Press eBooks”
      Finasteride increases hair count and improves hair growth with low risk of side effects.
      Androgenetic Alopecia: Case Study and Treatment Options

      research Androgenetic Alopecia

      November 2015 in “Springer eBooks”
      Hair loss treated with minoxidil, finasteride, laser/light, hair transplant, and scalp prostheses; more research needed for skin of color.
      Proceedings of the Ninth World Congress for Hair Research 2015

      research Proceedings of the Ninth World Congress for Hair Research (2015)

      January 2017 in “Journal of Investigative Dermatology Symposium Proceedings”
      The 2015 Hair Research Congress concluded that stem cells, maraviroc, and simvastatin could potentially treat Alopecia Areata, topical minoxidil, finasteride, and steroids could treat Frontal Fibrosing Alopecia, and PTGDR2 antagonists could also treat alopecia. They also found that low-level light therapy could help with hair loss, a robotic device could assist in hair extraction, and nutrition could aid hair growth. They suggested that Alopecia Areata is an inflammatory disorder, not a single disease, indicating a need for personalized treatments.